Related Experiment Video

Updated: Oct 22, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.2K

Toward Understanding the Mechanisms of Malignant Peripheral Nerve Sheath Tumor Development

Teddy Mohamad1, Camille Plante1, Jean-Philippe Brosseau1,2

  • 1Department of Biochemistry and Functional Genomics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.

International Journal of Molecular Sciences
|August 27, 2021
PubMed

Insights

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive cancers linked to neurofibromatosis type I. This review explores MPNST development, models, microenvironment, and signaling pathways for future research.

Area of Science:

  • Oncology
  • Cancer Biology
  • Genetics

Background:

  • Malignant peripheral nerve sheath tumors (MPNSTs) are rare, aggressive cancers.
  • MPNSTs arise from the neural crest cell lineage.
  • These tumors are frequently associated with neurofibromatosis type I (NF1).

Purpose of the Study:

  • To review current knowledge on MPNST development.
  • To discuss research perspectives and future directions for MPNST.
  • To highlight MPNST as an unmet clinical need.

Main Methods:

  • Literature review of MPNST research.
  • Synthesis of information on natural history and precursor lesions.
  • Analysis of existing mouse models for MPNST progression.

Main Results:

  • MPNST development involves a complex natural history.
  • Mouse models are crucial for studying MPNST progression.
  • The tumor microenvironment and signaling pathways play significant roles.

Conclusions:

  • Further research into MPNST biology is critical.
  • Understanding MPNST development can lead to novel therapeutic strategies.
  • Targeting the tumor microenvironment and signaling pathways shows promise.
Keywords:
malignant peripheral nerve sheath tumormouse modelsneurofibromaneurofibromatosis type Itumor microenvironment

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.3K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.9K

Related Concept Videos

Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K